Kc. Zimmermann et al., CONSTITUTIVE CYCLOOXYGENASE-2 EXPRESSION IN HEALTHY-HUMAN AND RABBIT GASTRIC-MUCOSA, Molecular pharmacology, 54(3), 1998, pp. 536-540
Selective cyclooxygenase (COX)-2 inhibitors are expected to cause fewe
r gastric side effects because of sparing of COX-1-dependent prostagla
ndin (PG) synthesis in the gastric mucosa. However, the possible contr
ibution of COX-2 to overall gastric PG biosynthesis is not known. This
study demonstrates constitutive expression of COX-2 mRNA and protein
in apparently healthy human and rabbit gastric mucosa. This basal expr
ession of COX-2 protein in human gastric mucosa was increased by lipop
olysaccharide and phorbol ester, indicating its up-regulation in respo
nse to appropriate stimuli. The functional significance of COX-2-depen
dent PG formation was studied in terms of PGE(2) generation in the rab
bit mucosa and its inhibition by the COX-2-selective inhibitor flosuli
de. There was concentration-dependent (IC50 = 107 +/- 55 nM) and ultim
ately complete inhibition of PGE(2) generation by flosulide. In additi
on, gastric mucosa generated 15-hydroxyeicosatetraenoic acid upon trea
tment with acetylsalicylic acid. The data suggest an important role fo
r COX-2-dependent PG production in apparently healthy gastric mucosa a
nd raise the issue of whether selective COX-2 inhibitors might also in
terfere with physiological PG formation and actions in the stomach.